COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 1326: Articles 13251-13260  | Next

Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern
Mothes, W., Li, W., Chen, Y., Prevost, J., Ullah, I., Lu, M., Gong, S. Y., Tauzin, A., Gasser, R., Vezina, D., Anand, S. P., Goyette, G., Chaterjee, D., Ding, S., Tolbert, W. D., Grunst, M. W., Bo, Y., Zhang, S., Richard, J., Zhou, F., Huang, R. K., Esser, L., Zeher, A., Cote, M., Kumar, P., Sodroski, J., Xia, D., Uchil, P. D., Pazgier, M., Finzi, A.
10.1101/2021.08.02.454546 — Posted: 2021-08-03
Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters
Kulkarni, R., Chen, W.-C., Lee, Y., Kao, C.-F., Hu, S.-L., Ma, H.-H., Jan, J.-T., Liao, C.-C., Liang, J.-J., Ko, H.-Y., Sun, C.-P., Lin, Y.-S., Wang, Y.-C., Wei, S.-C., Lin, Y.-L., Ma, C., Chao, Y.-C., Chou, Y.-C., Chang, W.
10.1101/2021.08.03.454910 — Posted: 2021-08-03
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.
Hurlburt, N., Homad, L., Siha, I., Jenewein, M. F., MacCamy, A., Wan, Y.-H., Boonyaratanakornkit, J., Sholukh, A. M., Zhou, P., Burton, D., Andrabi, R., Stamatatos, L., Pancera, M., McGuire, A.
10.1101/2021.08.02.454829 — Posted: 2021-08-03
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization
Lapuente, D., Fuchs, J., Willar, J., Antao, A. V., Everlein, V., Uhlig, N., Issmail, L., Schmidt, A., Oltmanns, F., Peter, A. S., Mueller-Schmucker, S., Irrgang, P., Fraedrich, K., Cara, A., Hoffmann, M., Poehlmann, S., Ensser, A., Pertl, C., Willert, T., Thirion, C., Grunwald, T., Ueberla, K., Tenbusch, M.
10.1101/2021.08.03.454858 — Posted: 2021-08-03
The timing of natural killer cell response in coronavirus infection: a concise model perspective
Xu, X., Sneppen, K.
10.1101/2021.08.02.454730 — Posted: 2021-08-03
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., Valtanen, P. G., Al-Delfi, Z., Gummow, J. A., Ferguson, C., O'Connor, S., Reddi, B., Shaw, D., Kok-Lim, C., Gleadle, J. M., Beard, M. R., Barry, S. C., Grubor-Bauk, B., Lynn, D. J.
10.1101/2021.07.30.21261234 — Posted: 2021-08-03 Discussion: Onsite
High parental vaccine motivation at a neighborhood-based vaccine and testing site serving a predominantly Latinx community
Naso, J., Rojas, S., Peng, J., Marquez, C., Contreras, M., Castellanos, E., Rojas, S., Rubio, L., Jones, D., Jacobo, J., Black, D., Tulier-Laiwa, V., Martinez, J., Chamie, G., Pilarowski, G., Derisi, J., Havlir, D., Petersen, M.
10.1101/2021.07.30.21261274 — Posted: 2021-08-03
SARS-CoV-2 fears green: the chlorophyll catabolite Pheophorbide a is a potent antiviral
Jimenez-Aleman, G. H., Castro, V., Longdaitsbehere, A., Gutierrez-Rodriguez, M., Garaigorta, U., Gastaminza, P., Solano, R.
10.1101/2021.07.31.454592 — Posted: 2021-08-02
Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 responses
Ndeupen, S., Bouteau, A., Herbst, C., Qin, Z., Hutchins, Z., Kurup, D., Diba, L. Z., Igyarto, B.
10.1101/2021.08.01.454662 — Posted: 2021-08-02
Analysis of B-cell receptor repertoires in COVID-19 patients using deep embedded representations of protein sequences
Kim, I., Byun, S. Y., Kim, S., Choi, S., Noh, J., Chung, J., Kim, B. G.
10.1101/2021.08.02.454701 — Posted: 2021-08-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).